Evidence map›Paper›PMID 36737838›Full record

Trial reportTrials2023

A post-market cluster randomized controlled trial of the effect of the TENA SmartCare Change Indicator™ on urinary continence care efficiency and skin health in older nursing home residents.

Muyibat Omotunde, Fredrik Agholme, Arne Böhling, Nicole Huige, Hardy Schweigel, Daniela Hayder-Beichel, Robert Reidy, Adrian Wagg

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05247047 (A Post-market Cluster Randomized Controlled Trial of the Effect of the TENA SmartCare Change Indicator on Continence Care Efficiency and Skin Health in Long Term Care Facilities), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05247047 nacompletednot on this map

A Post-market Cluster Randomized Controlled Trial of the Effect of the TENA SmartCare Change Indicator on Continence Care Efficiency and Skin Health in Long Term Care Facilities

TypeinterventionalSponsorEssity Hygiene and Health ABRan2022 to 2024Enrolled108ConditionsUrinary IncontinenceArmsTENA SmartCare Change Indicator
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Muyibat OmotundeDivision of Geriatric Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Fredrik AgholmeEssity Hygiene & Health AB, 405 03, Gothenburg, Sweden.
Arne BöhlingEssity/BSN Medical GmbH, Schützenstraße 1-3, 22765, Hamburg, Germany.
Nicole HuigeEssity Hygiene & Health AB, 405 03, Gothenburg, Sweden.
Hardy SchweigelEssity/BSN Medical GmbH, Schützenstraße 1-3, 22761, Hamburg, Germany.
Daniela Hayder-BeichelDepartment of Health, Hochschule Neiderrhein-University of Applied Sciences, Reinarzstr 49, 47805, Krefeld, Germany.
Robert ReidyStaburo GmbH, Aschauer Strasse 26a, 81549, Munich, Germany.
Adrian WaggDivision of Geriatric Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada. adrian.wagg@ulberta.ca.ORCID http://orcid.org/0000-0002-5372-530X
Essity (Sweden) · SEMSH Medical School Hamburg – University of Applied Sciences and Medical University · DEUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrinary continence care for residents of nursing homes who are unable to communicate their toileting needs usually involves care aides manually checking continence products (pads) to determine the level of urine saturation prior to changing. The TENA SmartCare Change Indicator is a medical device which estimates urine saturation and notifies caregivers of the optimal time for pad changes. This study will seek to examine the effect of the TENA SmartCare Change Indicator on urinary continence care efficiency and skin health, in comparison to usual care.

methodsThis cluster randomized controlled trial (NCT05247047) involving older nursing home residents with urinary incontinence unable to consistently indicate their toileting needs, and their care aides, will compare technology-based and usual continence care over a period of 8 weeks. Co-primary endpoints of superiority in continence care efficiency and non-inferiority in the maintenance of skin health will be assessed. Secondary outcomes will examine the resident quality of life, sleep quality, responsive behaviours, changes in pad use and leakage episodes outside the pad. Change in care aide work engagement, job satisfaction and rushed tasks will be assessed. Benefits and challenges with the use of the device for continence care will be identified from the perspectives of the care staff. DISCUSSION: Urinary continence assessment and care in nursing homes is reported as suboptimal and threatening to dignity. Data on the utility and effect of technological solutions for improving urinary continence care are few and conflicting. If shown effective, this technological solution has the potential to improve the care for older residents and improve the working lives of caregiving staff who look after this most vulnerable section of the population.

trial registrationClinicalTrials.gov NCT05247047. Registration date is Feb 18, 2022.

Indexed as

Quality of LifeUrinary IncontinenceAgedHumansNaltrexoneNursing Homes6,6'-(ethylenebis(oxyethyleneimino))bis(17-cyclopropylmethyl)-4,5-epoxymorphinan-3,14-diolNaltrexoneCare aide continence careCaregiversDigital health technologyMedical deviceNursing homes (long-term care facilities)Older adultsResidentsTENA SmartCare Change IndicatorUrinary incontinence

Identifiers

PMID36737838
PMCPMC9895969
OpenAlexW4319161784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.